Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2020-12-21 Sale |
2020-12-22 4:55 pm |
CRISPR Therapeutics AG | CRSP | Ho Tony W Executive VP, Head of R&D |
23,551 | $149.23 | $3,514,610 | 270,413 (Direct) |
View |
| 2020-06-22 Sale |
2020-06-24 5:58 pm |
CRISPR Therapeutics AG | CRSP | Ho Tony W Executive VP, Head of R&D |
7,158 | $75.04 | $537,123 | 33,747 (Direct) |
View |
| 2020-05-22 Sale |
2020-05-27 4:32 pm |
CRISPR Therapeutics AG | CRSP | Ho Tony W Executive VP, Head of R&D |
6,700 | $70.13 | $469,884 | 40,905 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-06-11 Option Award |
2024-06-13 8:00 pm |
2025-06-11 2034-06-11 |
iTeos Therapeutics Inc. | ITOS | Ho Tony W Director |
24,200 | $0 | 24,200 (Direct) |
View |
| 2023-06-13 Option Award |
2023-06-15 7:55 pm |
2024-06-13 2033-06-13 |
iTeos Therapeutics Inc. | ITOS | Ho Tony W Director |
22,383 | $0 | 22,383 (Direct) |
View |
| 2022-06-09 Option Award |
2022-06-10 7:52 pm |
N/A 2032-06-09 |
iTeos Therapeutics Inc. | ITOS | Ho Tony W Director |
17,538 | $0 | 17,538 (Direct) |
View |
| 2021-12-06 Tax Withholding |
2021-12-07 8:00 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Ho Tony W Executive VP, Head of R&D |
12,607 | $69.17 | 65,697 (Direct) |
View |
| 2021-12-03 Exercise |
2021-12-07 8:00 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Ho Tony W Executive VP, Head of R&D |
26,667 | $0 | 65,697 (Direct) |
View |
| 2021-10-15 Option Award |
2021-10-18 8:00 pm |
N/A 2031-10-15 |
CRISPR Therapeutics AG | CRSP | Ho Tony W Executive VP, Head of R&D |
13,800 | $0 | 13,800 (Direct) |
View |
| 2021-06-17 Option Award |
2021-06-21 8:21 pm |
N/A 2031-06-17 |
iTeos Therapeutics Inc. | ITOS | Ho Tony W Director |
4,560 | $0 | 4,560 (Direct) |
View |
| 2021-04-29 Option Award |
2021-05-03 7:01 pm |
N/A 2031-04-29 |
iTeos Therapeutics Inc. | ITOS | Ho Tony W Director |
33,217 | $0 | 0 (Direct) |
View |
| 2021-03-11 Option Award |
2021-03-12 5:41 pm |
N/A 2031-03-11 |
CRISPR Therapeutics AG | CRSP | Ho Tony W Executive VP, Head of R&D |
32,334 | $0 | 70,638 (Direct) |
View |
| 2021-03-10 Exercise |
2021-03-12 5:41 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Ho Tony W Executive VP, Head of R&D |
4,583 | $0 | 70,638 (Direct) |
View |
| 2021-03-10 Tax Withholding |
2021-03-12 5:41 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Ho Tony W Executive VP, Head of R&D |
2,141 | $124.15 | 70,638 (Direct) |
View |
| 2021-03-05 Tax Withholding |
2021-03-09 5:40 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Ho Tony W Executive VP, Head of R&D |
1,585 | $114.65 | 35,862 (Direct) |
View |
| 2021-03-05 Exercise |
2021-03-09 5:40 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Ho Tony W Executive VP, Head of R&D |
3,333 | $0 | 35,862 (Direct) |
View |
| 2020-12-21 Exercise |
2020-12-22 4:55 pm |
N/A 2027-08-01 |
CRISPR Therapeutics AG | CRSP | Ho Tony W Executive VP, Head of R&D |
23,551 | $0 | 270,413 (Direct) |
View |
| 2020-12-21 Exercise |
2020-12-22 4:55 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Ho Tony W Executive VP, Head of R&D |
23,551 | $16.9 | 270,413 (Direct) |
View |
| 2020-10-05 Option Award |
2020-10-06 5:32 pm |
N/A 2030-10-05 |
CRISPR Therapeutics AG | CRSP | Ho Tony W Executive VP, Head of R&D |
16,666 | $0 | 16,666 (Direct) |
View |